Go to homepage

Collaboration is largest adaptation of Dialyze Direct’s staff-assisted home hemodialysis treatment model

Brooklyn, N.Y., May 29, 2019 /PR Newswire/ — Dialyze Direct, LLC, a leader in patient-focused treatment modalities to improve quality of life for people suffering from kidney disease, has entered into a national cooperation agreement with HCR ManorCare, the nation’s leading not-for-profit provider of short and long-term skilled nursing and rehabilitation services. Dialyze Direct will provide staff-assisted in-home hemodialysis services at HCR ManorCare’s ManorCare Health Services skilled nursing facilities (SNF) across multiple states.

At each participating SNF, Dialyze Direct will facilitate comprehensive, turn-key dialysis solutions that will allow patients with end-stage renal disease (ESRD) to receive patient-centric dialysis treatments without leaving the facility. Dialyze Direct’s highly-trained team of physicians, nurses, technicians, renal dietitians and social workers will implement a personalized plan of care in coordination with ManorCare’s skilled nursing and rehab care team. Dialyze Direct staff will perform and manage the complete treatment process and provide all necessary support staff.Additionally, Dialyze Direct will provide ongoing training and education to ManorCare’s staff on best care practices for dialysis patients’ pre and post-dialysis treatment.

“Our world renowned nephrology leadership team deploys the most advanced home dialysis technology to provide treatment that addresses the specific needs of elderly patients, SNFs, hospitals and payors. Dialyze Direct’s patient-centric model of care focuses on significantly improving complex co-morbidities, and provides the best chance to reduce re-hospitilizations” said Josh Rothenberg, Chief Operating Officer of Dialyze Direct. “Partnering with ManorCare enables us to extend our compassionate care model to a wider audience, helping patients improve their quality of life while also lessening the overall cost burden on the healthcare ecosystem.”

Traditional dialysis service requires SNF patients to leave their facility three times a week for hours at a time, disrupting their day-to-day care, meals and rehabilitation plans. Under Dialyze Direct’scare model, ManorCare patients will receive in-home treatment up to five times a week (pursuant to a physicians’ order) at their skilled nursing facility, for approximately two and a half hours. Recovery time for Dialyze Direct’s in-home dialysis treatment is typically around 30 to 60 minutes versus eight to nine hours for traditional dialysis, which can escalate to an average of 21 hours for elderly patients1 . Shorter, more frequent dialysis more closely mimics the operation of healthy kidneys and keeps the amount of toxins and water build-up in the blood to a minimum.

Jaber, B. L., MD, MS, & Lee, Y., MS., et al. (2010). Effect of Daily Hemodialysis on Depressive Symptoms and Postdialysis Recovery Time: Interim Report From the FREEDOM Study (pp. 531-539, Rep.). American Journal of Kidney Diseases.

“For end-stage renal disease patients, dialysis is a life-saving, yet incredibly taxing, medical treatment. With Dialyze Direct’s in-home hemodialysis services, we are looking to change that for residents in our skilled nursing facilities,” said Rami Ubaydi, Vice President and General Manager for HCR
ManorCare. “By eliminating the travel time, logistics, and cost associated with transporting patients to outpatient facilities, while simultaneously improving the quality of dialysis care provided to our patients, our skilled nursing staff will be able to focus on providing quality care and allow our patients to continue their normal social and medical activities.”

According to the Centers for Disease Control and Prevention (CDC), more than 30 million people in the United States (15% of the US population) have chronic kidney disease (CKD), and kidney disease is the ninth leading cause of death in the United States. End-stage renal disease (ESRD), also called kidney failure, is the last stage of CKD. With ESRD, the kidneys are no longer able to filter wastes and excess fluid from the body, causing toxic levels of fluid, electrolytes and wastes to build up in the blood, which makes dialysis or a kidney transplant is necessary. According to the United States Renal Data System (USRDS), more than 726,000 people in the United States are being treated for ESRD, approximately 509,000 of which are receiving dialysis, numbers which are on the rise. The annual Medicare spending to treat ESRD in the U.S. is approximately $35 billion.

About HCR ManorCare

ManorCare Health Services centers are part of HCR ManorCare, a wholly-owned subsidiary of ProMedica, a mission-based, not-for-profit integrated healthcare organization which includes a network of 13 hospitals, 2,600 physicians, a health plan, 400 skilled nursing and rehabilitation centers, memory care communities, outpatient rehabilitation clinics, home health and hospice agencies. Driven by its Mission to improve health and well-being, ProMedica has been nationally recognized for its advocacy programs and efforts to address social determinants of health. For more information about HCR ManorCare, please visit www.hcr-manorcare.com.

About Dialyze Direct

Dialyze Direct is a compassionate, patient-focused company developing treatment modalities to improve quality of life for people suffering from kidney disease by implementing an innovative dialysis care model. By delivering a dialysis method that lowers hospitalizations, infection rates, transportation costs and other patient stressors, Dialyze Direct’s proprietary care model achieves significantly improved outcomes and lowers costs. With a mission to build the next generation kidney care infrastructure, Dialyze Direct works with the world’s best nephrology talent to develop new technology and methods, evolving the treatment options nephrologists have at their disposal.

NxStage Medical, Inc. NXTM recently announced that its subsidiary NxStage Kidney Care is partnering Dialyze Direct for supporting the needs of patients who need on-site skilled-nursing facilities (SNF) for dialysis treatment in Ohio.

In an initiative to reduce transportation costs, re-hospitalization rates and provide dialysis care on site, NxStage will now leverage on its System One platform and Dialyze Direct’s unique model for treating geriatric SNF patients with end stage renal disease (ESRD).

On-site dialysis at SNF is hassle free and counters organizational and operational challenges for dialysis centers and care facilities. NxStage System One helps avoid the hassles of regular transportation for a patient to an off-site dialysis center (almost thrice a week).

Results for on-site dialysis at SNF have been significantly favorable for patients because it has witnessed reductions in both mortality and hospitalizations. Furthermore, patients with higher flexibility are eligible for rehabilitation therapy and social activities.

Notably, U.S.-based Dialyze Direct provides innovative and staff-assisted home hemodialysis services to geriatric patients in skilled nursing facilities (SNF).

Future Trends

Data from Markets And Markets reveal that the global hemodialysis and peritoneal dialysis market is expected to reach a worth of $83.89 billion by 2021, multiplying at a CAGR of 6.0%. Per management, the niche market, especially in the SNF space, has substantial opportunities to improve overall cost of care.

Furthermore, an increased rate of ESRD cases among patients enhances probabilities of NxStage outperformance in the niche space in the near term. In this regard, two major players in the hemodialysis market include DaVita Healthcare Partners, Inc. DVA and Baxter International, Inc. BAX .

NxStage Getting Acquired

Earlier this month, German dialysis provider Fresenius Medical Care FMS signed an agreement to acquire all outstanding shares of NxStage for $30 a share. The transaction has been valued at $2 billion and is subject to close by 2018, on approval of NxStage stockholders and other customary conditions. We note that NxStage has been gaining prominence in the market of late with products like NxStage PureFlow SL Dialysis Preparation System, Nx2me Connected Health and NxStage System One.